J 2020

Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis

KRAJICKOVA, Dagmar; Jiří KRÁL; Roman HERZIG; L'udovit KLZO; Antonin KRAJINA et al.

Základní údaje

Originální název

Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis

Autoři

KRAJICKOVA, Dagmar; Jiří KRÁL; Roman HERZIG; L'udovit KLZO; Antonin KRAJINA; Jaroslav HAVELKA; Libor SIMUNEK; Oldrich VYSATA; Tran Van QUANG; Michal BAR a Martin VALIS

Vydání

Scientific Reports, USA, NATURE RESEARCH, 2020, 2045-2322

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30103 Neurosciences

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.380

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/20:00118096

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

cerebral venous sinus thrombosis

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 2. 2. 2021 10:36, Mgr. Tereza Miškechová

Anotace

V originále

We aimed was to assess the factors influencing therapy choice and clinical outcome after 3-4 months in patients with cerebral venous sinus thrombosis (CVST). In a retrospective, bi-centric study, the set consisted of 82 consecutive CVST patients (61 females; mean age 33.5 +/- 15.7 years). Following data were collected: baseline characteristics, presence of gender-specific risk factors (GSRF), location and extent of venous sinus impairment, clinical presentation, type of treatment, recanalization, presence of parenchymal lesions, and clinical outcome after 3-4 months (assessed using the modified Rankin Scale [mRS], with excellent outcome defined as mRS 0-1). Multivariate logistic regression analysis was used for statistical evaluation. After 3-4 months, complete recovery was achieved in 41 (50%) and excellent clinical outcome in 67 (81.7%) patients. Female sex (OR 0.11; p=0.0189) and presence of focal neurologic deficit (OR 0.16; p=0.0165) were identified as significant independent negative predictors and, the presence of GSRF (OR 15.63; p=0.0011) as significant independent positive predictor of excellent clinical outcome. In conclusion, in our CVST patients, the presence of GSRF was associated with excellent clinical outcome, while the female sex itself was associated with poorer clinical outcome.